US FDA outlines clinical considerations for therapeutic cancer vaccines
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued a final guidance document outlining critical clinical considerations for investigational studies of therapeutic cancer vaccines1,2.